266 related articles for article (PubMed ID: 19124763)
21. Evaluation of blood-brain barrier function by quotient alpha2 macroglobulin and its relationship with interleukin-6 and complement component 3 levels in neuropsychiatric systemic lupus erythematosus.
Asano T; Ito H; Kariya Y; Hoshi K; Yoshihara A; Ugawa Y; Sekine H; Hirohata S; Yamaguchi Y; Sato S; Kobayashi H; Migita K; Ohira H; Hashimoto Y; Watanabe H
PLoS One; 2017; 12(10):e0186414. PubMed ID: 29036223
[TBL] [Abstract][Full Text] [Related]
22. Clinical analysis of cerebrospinal fluid interleukin-6 in neuropsychiatric systemic lupus erythematosus.
Horai Y; Watanabe H; Miyamura T; Takahama S; Hirata A; Nakamura M; Ando H; Minami R; Yamamoto M; Suematsu E
Fukuoka Igaku Zasshi; 2010 Feb; 101(2):34-40. PubMed ID: 20560477
[TBL] [Abstract][Full Text] [Related]
23. Role of serum autoantibodies in blood brain barrier damages in neuropsychiatric systemic lupus erythematosus.
Hirohata S; Sakuma Y; Matsueda Y; Arinuma Y; Yanagida T
Clin Exp Rheumatol; 2018; 36(6):1003-1007. PubMed ID: 29846157
[TBL] [Abstract][Full Text] [Related]
24. Association of antibodies to the NR1 subunit of N-methyl-D-aspartate receptors with neuropsychiatric systemic lupus erythematosus.
Ogawa E; Nagai T; Sakuma Y; Arinuma Y; Hirohata S
Mod Rheumatol; 2016; 26(3):377-83. PubMed ID: 26429674
[TBL] [Abstract][Full Text] [Related]
25. Raised monocyte chemotactic protein-1 (MCP-1)/CCL2 in cerebrospinal fluid of patients with neuropsychiatric lupus.
Iikuni N; Okamoto H; Yoshio T; Sato E; Kamitsuji S; Iwamoto T; Momohara S; Taniguchi A; Yamanaka H; Minota S; Kamatani N
Ann Rheum Dis; 2006 Feb; 65(2):253-6. PubMed ID: 16410530
[TBL] [Abstract][Full Text] [Related]
26. Utility of osteopontin in cerebrospinal fluid as a diagnostic marker for neuropsychiatric systemic lupus erythematosus.
Kitagori K; Yoshifuji H; Oku T; Ayaki T; Kuzuya A; Nakajima T; Akizuki S; Nakashima R; Murakami K; Ohmura K; Hirayama Y; Takahashi R; Mimori T
Lupus; 2019 Mar; 28(3):414-422. PubMed ID: 30744522
[TBL] [Abstract][Full Text] [Related]
27. Absence of Neuronal Autoantibodies in Neuropsychiatric Systemic Lupus Erythematosus.
Varley JA; Andersson M; Grant E; Berretta A; Zandi MS; Bondet V; Duffy D; Hunt D; Piehl F; Waters P; Irani SR
Ann Neurol; 2020 Dec; 88(6):1244-1250. PubMed ID: 32951275
[TBL] [Abstract][Full Text] [Related]
28. Disease activity, autoantibodies, and inflammatory molecules in serum and cerebrospinal fluid of patients with Systemic Lupus Erythematosus and Cognitive Dysfunction.
Duarte-García A; Romero-Díaz J; Juárez S; Cicero-Casarrubias A; Fragoso-Loyo H; Núñez-Alvarez C; Llorente L; Sánchez-Guerrero J
PLoS One; 2018; 13(5):e0196487. PubMed ID: 29723220
[TBL] [Abstract][Full Text] [Related]
29. Relationship between elevated cerebrospinal fluid levels of plasminogen activator inhibitor 1 and neuronal destruction in patients with neuropsychiatric systemic lupus erythematosus.
Kwieciński J; Kłak M; Trysberg E; Blennow K; Tarkowski A; Jin T
Arthritis Rheum; 2009 Jul; 60(7):2094-101. PubMed ID: 19565516
[TBL] [Abstract][Full Text] [Related]
30. Cerebrospinal fluid levels of a proliferation-inducing ligand (APRIL) are increased in patients with neuropsychiatric systemic lupus erythematosus.
Hopia L; Thangarajh M; Khademi M; Laveskog A; Wallström E; Svenungsson E; Andersson M
Scand J Rheumatol; 2011; 40(5):363-72. PubMed ID: 21585290
[TBL] [Abstract][Full Text] [Related]
31. Predictors of clinical outcomes in patients with neuropsychiatric systemic lupus erythematosus.
Ichinose K; Arima K; Umeda M; Fukui S; Nishino A; Nakashima Y; Suzuki T; Horai Y; Koga T; Kawashiri SY; Iwamoto N; Fujikawa K; Aramaki T; Tamai M; Nakamura H; Sato S; Origuchi T; Kawakami A
Cytokine; 2016 Mar; 79():31-7. PubMed ID: 26745468
[TBL] [Abstract][Full Text] [Related]
32. Brain magnetic resonance imaging, cerebrospinal fluid, and autoantibody profile in 118 patients with neuropsychiatric lupus.
Tan Z; Zhou Y; Li X; Wang G; Tao J; Wang L; Ma Y; Li X
Clin Rheumatol; 2018 Jan; 37(1):227-233. PubMed ID: 29103181
[TBL] [Abstract][Full Text] [Related]
33. Anti-U1 RNP antibodies in cerebrospinal fluid are associated with central neuropsychiatric manifestations in systemic lupus erythematosus and mixed connective tissue disease.
Sato T; Fujii T; Yokoyama T; Fujita Y; Imura Y; Yukawa N; Kawabata D; Nojima T; Ohmura K; Usui T; Mimori T
Arthritis Rheum; 2010 Dec; 62(12):3730-40. PubMed ID: 20722023
[TBL] [Abstract][Full Text] [Related]
34. The clinical significance of ubiquitin carboxyl hydrolase L1 and its autoantibody in neuropsychiatric systemic lupus erythematosus.
Li X; Sun J; Mu R; Gan Y; Wang G; He J; Yi L; Wang Q; Sun X; Li Z
Clin Exp Rheumatol; 2019; 37(3):474-480. PubMed ID: 30418114
[TBL] [Abstract][Full Text] [Related]
35. Expression of S100B protein levels in serum and cerebrospinal fluid with different forms of neuropsychiatric systemic lupus erythematosus.
Yang XY; Lin J; Lu XY; Zhao XY
Clin Rheumatol; 2008 Mar; 27(3):353-7. PubMed ID: 17955279
[TBL] [Abstract][Full Text] [Related]
36. Novel anti-suprabasin antibodies may contribute to the pathogenesis of neuropsychiatric systemic lupus erythematosus.
Ichinose K; Ohyama K; Furukawa K; Higuchi O; Mukaino A; Satoh K; Nakane S; Shimizu T; Umeda M; Fukui S; Nishino A; Nakajima H; Koga T; Kawashiri SY; Iwamoto N; Tamai M; Nakamura H; Origuchi T; Yoshida M; Kuroda N; Kawakami A
Clin Immunol; 2018 Aug; 193():123-130. PubMed ID: 29162406
[TBL] [Abstract][Full Text] [Related]
37. Intrathecal cytokine and chemokine profiling in neuropsychiatric lupus or lupus complicated with central nervous system infection.
Lu XY; Zhu CQ; Qian J; Chen XX; Ye S; Gu YY
Lupus; 2010 May; 19(6):689-95. PubMed ID: 20179168
[TBL] [Abstract][Full Text] [Related]
38. Elevated levels of soluble fractalkine in active systemic lupus erythematosus: potential involvement in neuropsychiatric manifestations.
Yajima N; Kasama T; Isozaki T; Odai T; Matsunawa M; Negishi M; Ide H; Kameoka Y; Hirohata S; Adachi M
Arthritis Rheum; 2005 Jun; 52(6):1670-5. PubMed ID: 15934075
[TBL] [Abstract][Full Text] [Related]
39. Clinical significance of anti-DNA/N-methyl-D-aspartate receptor 2 antibodies in de novo and post-steroid cases with neuropsychiatric systemic lupus erythematosus.
Fujieda Y; Mader S; Jeganathan V; Arinuma Y; Shimizu Y; Kato M; Oku K; Minami A; Shimizu C; Yasuda S; Atsumi T
Int J Rheum Dis; 2019 Mar; 22(3):443-448. PubMed ID: 30358102
[TBL] [Abstract][Full Text] [Related]
40. Chemokine (C-X-C motif) ligand (CXCL)10 in autoimmune diseases.
Antonelli A; Ferrari SM; Giuggioli D; Ferrannini E; Ferri C; Fallahi P
Autoimmun Rev; 2014 Mar; 13(3):272-80. PubMed ID: 24189283
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
